DNA -
Ginkgo Bioworks Holdin
10.22
+0.85 (+9.07%)
As of December 26, 2024 4:00 pm EST
Quote Detail
| Last | 10.22 |
|---|---|
| Change | 0.85 |
| Change % | 9.07 |
| Bid | 10.13 X 4000 |
| Ask | 10.45 X 100 |
| Volume | 1.11 M |
| Shares | 54.48 M |
| Market Cap | 510.47 M |
| Open | 9.07 |
|---|---|
| High | 10.48 |
| Low | 8.92 |
| Prev Close | 9.37 |
| 52 Wk High | 74.00 |
| 52 Wk Low | 5.26 |
| EPS | -12.8997 |
| P/E | n.a. |
| Div Yield | n.a. |
Market Headlines
Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program
BOSTON, Dec. 17, 2024 /PRNewswire via COMTEX News Network/ -- Ginkgo Bioworks to apply its mammalian cell engineering expertise to develop new cell-based systems for treating and monitoring...
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
BOSTON, Nov. 12, 2024 /PRNewswire via COMTEX News Network/ -- Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress...
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
BOSTON, Nov. 12, 2024 /PRNewswire via COMTEX News Network/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the...
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation
BOSTON, Nov. 5, 2024 /PRNewswire via COMTEX News Network/ -- Presentation and Q&A session scheduled for post-market on Tuesday, November 12, 2024
